Aug 31, 2026 04:03PM
Aug 24, 2026 08:51AM
Aug 19, 2026 04:04PM
Aug 18, 2026 08:07AM
Aug 12, 2026 08:26AM
Jul 31, 2026 08:22AM
Mar 16, 2026 08:21AM SciSparc subsidiary files patent application for depression treatment
Mar 13, 2026 07:46AM
Mar 12, 2026 07:55AM
Mar 10, 2026 08:59AM
Feb 3, 2026 04:38PM
Jan 12, 2026 04:02PM
Dec 30, 2025 08:18AM
Dec 1, 2025 08:32AM SciSparc to acquire GERD device portfolio from Xylo Technologies
Nov 20, 2025 06:45AM
Nov 17, 2025 07:55AM
Oct 30, 2025 09:25AM
Oct 24, 2025 07:55AM
Oct 23, 2025 04:04PM
Oct 23, 2025 08:58AM
Oct 23, 2025 08:26AM N2OFF completes acquisition of cancer drug discovery firm MitoCareX
Oct 20, 2025 07:42AM
Oct 15, 2025 07:05AM
Oct 6, 2025 06:41AM
Sep 29, 2025 04:03PM
Sep 25, 2025 04:01PM
Sep 25, 2025 07:05AM
Aug 28, 2025 09:24AM SciSparc shareholders approve merger with Israeli auto importer AutoMax
Aug 28, 2025 06:53AM
Aug 7, 2025 07:32AM
Jul 30, 2025 04:36PM
Jul 30, 2025 08:21AM
Jul 22, 2025 09:08AM
Jun 24, 2025 05:03PM
May 27, 2025 07:32AM SciSparc (SPRC) Announces Publication of Japanese Patent Application
Apr 25, 2025 08:00AM
Mar 10, 2025 07:27AM
Mar 3, 2025 08:25AM
Feb 27, 2025 08:45AM
Feb 26, 2025 09:29AM
Feb 18, 2025 07:17AM
Jan 15, 2025 07:34AM SciSparc (SPRC) Granted 180-Day Extension by Nasdaq to Regain Compliance with Minimum Bid Requirement
Jan 13, 2025 08:41AM
Jan 6, 2025 08:15AM
Jan 6, 2025 07:50AM
Dec 31, 2024 09:27AM
Dec 26, 2024 06:47AM
Dec 16, 2024 07:43AM
Sep 30, 2024 09:25AM SciSparc (SPRC) Secures FDA Green Light to US Launch of Phase IIb Clinical Trial for Tourette Syndrome Treatment
Sep 26, 2024 09:06AM

445,769 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All